1st Speaker
Cardiometabolic Risk Factors Among Participants of the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder
Alejandra Cabello Arreola, MD
2nd Speaker
PTSD in NICU Parents
John Powers, MD
Introduction
1st Speaker
Dr. Alejandra Cabello Arreola is a postdoctoral fellow in the Mood Disorders Unit from the Department of Psychiatry and Psychology at Mayo Clinic Rochester. She completed her training in Psychiatry in Monterrey, Mexico at Universidad Autonoma de Nuevo Leon, where she also received her medical degree and completed a one-year social service in research at the Department of Pharmacology. She is board certified by the Mexican Psychiatric Association and during her residency program did her international rotation at the same Mood Disorders Unit, confirming her interest and passion for research in this field. Dr. Cabello’s primary research interests center on better understanding the cardiometabolic risk factors in bipolar disorder patients and in the biological mechanisms of suicide from a proteomic perspective.
Introduction
2nd Speaker
John Powers is a PGY4 resident originally from Tulsa, Oklahoma. He received his BA from Merrimack College where he studied philosophy. After working variously as a teacher, manager of a group home, writer, and editor, he went to medical school and graduated in 2015 from the Medical School for International Health at Ben-Gurion University of the Negev in Beer Sheva, Israel. He is best known for being James and Nathanael’s dad, and Kathryn’s husband.
Learning Objectives
1st Speaker
- Identify the subcomponents of the metabolic syndrome and other cardiometabolic risk factors.
- Recognize the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder as a resource for the research community.
- Identify the subcomponents of the metabolic syndrome and other cardiometabolic risk factors.
Learning Objectives
2nd Speaker
- Recognize that having an infant in the NICU is a traumatic experience for the infant's parents and can lead to the development of PTSD.
- Recognize that untreated PTSD in NICU parents can result in negative outcomes for the parents AND the child.
- Review interventions that have been successful to treat PTSD in NICU mothers.
Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. Ethos will be implemented for all post presentation surveys. To document your attendance, please text the code given at the presentation to 507-200-3010. For questions, email rstpsychgr@mayo.edu
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s)
AMA
The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
APA
Continuing Educaiton (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Assocation (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the contents of the programs.
This activity is approved for a maximum of 1.0 credits. Credit is awarded only for actual instructional time.
Archived webcast available at: Psychiatry & Psychology Video Library
All participants MUST complete the evaluation in order to get CME or APA Credit.
1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
Relevant financial relationship(s) with industry:
Mark Frye, MD, Mayo Clinic
Grant Support - Assurex Health, Mayo Foundation, Myriad, NIAAA, NIMH, Pfizer
Consultant - Actify Neurotherapies, Allergan, Intra-Cellular Therapies, Inc., Janssen, Mitsubishi Tanabe Pharma Coporation, Myriad, Neuralstem Inc., Otsuka American Pharmaceutical, Sunovion, Takeda, Teva Pharmaceuticals
No relevant financial relationship(s) with industry:
Joshua Baruth, MD, Julia Benjamin, PhD, Ewa Bieber, MD, Deniz Doruk Camsari, MD., Melissa Goldschmidt, APRN, CNP, Ashli McLaughlin, Sohail Mohammad, MBBS, MPH, Charlene Nelson, Daniela Rakocevic, MD, Kate Zelic, PhD
Speakers:
Alejandro Cabello Arreola, MD
John Powers, MD
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.